Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human Microbiome Project (HMP) Reference Genomes

ABSTRACT: Genomes of microorganisms that have been isolated in and on the human body, to be used as Reference Genomes for the Human Microbiome Project (HMP)

PROVIDER: PRJNA28331 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR000066.fastq.gz	Fastqsanger.gz
	SRR000067.fastq.gz	Fastqsanger.gz
	SRR000068.fastq.gz	Fastqsanger.gz
	SRR000069.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 11014

Similar Datasets

Human Microbiome Project (HMP) Viral and Phage Reference Genomes

Project description:Genomes of viruses and phages that have been isolated in and on the human body, to be used as Reference Genomes for the Human Viral Microbiome Project (HMP)

| PRJNA73477 | ENA

Anopheles Reference Genomes Project

Project description:Anopheles Reference Genomes Project: Data and assemblies

| PRJEB51690 | ENA

Human Microbiome Project (HMP) Metagenome Projects

Project description:Deeper shotgun sequencing of human microbiome samples for the Human Microbiome Project (HMP)

| PRJNA43017 | ENA

Salmonella reference genomes

Project description:Salmonella reference genomes

| PRJEB49424 | ENA

Aerobic NO-exposed Chemostat Comparison of Wt & hmp mutant Responses

Project description:Escherichia coli strains MG1655 and an isogenic hmp::Tn5 mutant were grown in a New Brunswick Scientific Bioflow III Biofermentor under continuous culture (chemostat) conditions.. Cells were grown in defined media containing 8 mM glycerol as the sole and limiting source of energy and carbon. The working volume was 1 litre, and the dilution rate 0.1 h-1. For aerobic growth, the air-flow rate was 1 l/min, and the dissolved oxygen tension was maintained at 40% air saturation by measuring oxygen dissolved in the culture using a Broadley James D140 OxyProbe® electrode and automated adjustment of stirring rate. Cells were grown as above to steady-state, At steady-state, NOC-5 and NOC-7 was added to the chemostat culture and to the nutrient feed at a final concentration of 10 uM of each unless stated otherwise. Samples were taken after a period of 5 min exposure to NOC for subsequent analysis using microarrays. Cells were harvested directly into RNA Protect (Qiagen) to stabilize RNA, and total RNA was purified using Qiagen’s RNeasy Mini kit as recommended by the suppliers. Equal quantities of RNA from Wild type and hmp::Tn5 cultures were labelled using nucleotide analogues of dCTP containing either Cy3 or Cy5 fluorescent dyes. The average signal intensity and local background correction were obtained using a commercially available software package from Biodiscovery, Inc (Imagene, version 4.0 and GeneSight, version 3.5). The mean values from each channel were log2 transformed and normalised using the Lowess method to remove intensity-dependent effects in the log2(ratios) values. The Cy3/Cy5 fluorescent ratios were calculated from the normalized values Keywords: Mutant Comparison, stress response, nitric oxide, Hmp, chemostat, continuous culture Each strain was grown twice in seperate chemostat runs, exposed to NO. Samples were hybridised as WT vs hmp::Tn5 and each hybridisation had a corresponding dye-swap performed

2006-08-31 | E-GEOD-5139 | biostudies-arrayexpress

NIH Human Microbiome Project - Core Microbiome Sampling Protocol A (HMP-A)

Project description:<p>This first clinical study of the Human Microbiome Project (HMP) addresses whether individuals share a core human microbiome. It involves broad determination of the microbiota found in five anatomical sites: the oral cavity, skin, nasal cavity, gastrointestinal tract and vagina. This study will enroll approximately 300 healthy male and female adults, 18-40 years old, from two geographic regions of the US: Houston, TX and St. Louis, MO. The participation of healthy individuals will create a baseline for discovery of the core microbiota typically found in various areas of the human body. The information from this initial study can then be used to help assess the changes in the complement of microbiota found on or within diseased individuals.</p>

| phs000228.v3.p1 | EGA

Cardiomyopathy Genomes Project

Project description:Cardiomyopathy Genomes Project

| PRJNA1311161 | ENA

Cardiomyopathy Genomes Project

Project description:Cardiomyopathy Genomes Project

| PRJNA1311162 | ENA